|
Volumn 19, Issue 4, 2011, Pages 370-371
|
Monitoring in clozapine rechallenge after myocarditis
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
CLOZAPINE;
CREATINE KINASE;
NEUROLEPTIC AGENT;
TROPONIN I;
ADULT;
AGGRESSION;
AUDITORY HALLUCINATION;
BLOOD EXAMINATION;
CARDIOLOGIST;
CARDIOVASCULAR RISK;
CASE REPORT;
CREATINE KINASE BLOOD LEVEL;
DRUG DOSE TITRATION;
DRUG MONITORING;
DRUG RECHALLENGE;
DRUG WITHDRAWAL;
ECHOCARDIOGRAPHY;
ELECTROCARDIOGRAM;
EOSINOPHILIA;
HEART LEFT VENTRICLE FAILURE;
HEART LEFT VENTRICLE FUNCTION;
HUMAN;
LETTER;
LOW DRUG DOSE;
MALE;
MEDICAL HISTORY;
MYOCARDITIS;
NEGATIVE SYNDROME;
PARANOIA;
PARANOID SCHIZOPHRENIA;
PERSECUTORY DELUSION;
PHYSICAL EXAMINATION;
POSITIVE AND NEGATIVE SYNDROME SCALE;
PROTEIN BLOOD LEVEL;
PSYCHIATRIC DEPARTMENT;
PSYCHOSIS;
PSYCHOSOCIAL DISORDER;
REHABILITATION;
RISK BENEFIT ANALYSIS;
SYSTOLIC DYSFUNCTION;
THORAX PAIN;
VIOLENCE;
WEAPON;
ADULT;
ANTIPSYCHOTIC AGENTS;
CHEST PAIN;
CLOZAPINE;
HEART FUNCTION TESTS;
HUMANS;
MALE;
MYOCARDITIS;
SCHIZOPHRENIA, PARANOID;
TROPONIN;
VIOLENCE;
|
EID: 80052417091
PISSN: 10398562
EISSN: 14401665
Source Type: Journal
DOI: 10.3109/10398562.2011.580749 Document Type: Letter |
Times cited : (9)
|
References (2)
|